Tradestie Institutional Equity Comparison Engine

CHEK vs GEHC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GEHC Overall Edge

GEHC Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to GE HealthCare Technologies Inc. Common Stock (GEHC) driven by superior Valuation, Growth & Margin, Options & Structure while CHEK counters with relative strength in Momentum & Technical. Fundamentally, CHEK trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus GEHC at 14.7x Forward P/E and 13.8% operating margin (+7.2% YoY). In options structure, CHEK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GEHC sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GEHC
CHEK N/M vs GEHC 14.7x Fwd P/E
Growth & Margin Winner GEHC
Op Margin 0.0% vs 13.8% ยท YoY +0.0% vs +7.2%
Momentum & Technical Winner CHEK
1Y +95.8% vs +11.5% ยท 52W Pos 41% vs 71%
Options & Structure Winner GEHC
UNCLASSIFIED (N/A IV) vs SURGE (8th %ile IV)
CHEK NASDAQ
Check-Cap Ltd.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$1.61
+1.9% 1D
Market Cap $9.2M
1M Return +8.05%
1Y Return +95.84%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 54.0
GEHC NASDAQ
GE HealthCare Technologies Inc. Common Stock
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$80.64
-1.53% 1D
Market Cap $37.0B
1M Return +12.91%
1Y Return +11.52%
Forward P/E 14.7x
Unified AI Score
38.6 / 100 SELL
Tech 29.0 Fund 44.0 Flow 59.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CHEK +95.84% GEHC +11.52% Spread: +0.48 pp (GEHC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CHEK TTM Op. Margin: 0.0% GEHC TTM Op. Margin: 13.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CHEK vs GEHC. Trailing 12-month operating profitability (CHEK 0.0% vs GEHC 13.8%) and valuation multiples (CHEK N/M vs GEHC 14.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CHEK (1) vs GEHC (9)
Institutional Metric CHEK GEHC Criterion Row Winner
Market Capitalization Scale $9.2M $37.0B Larger Scale GEHC
Trailing P/E Ratio Valuation N/M 17.3x Lower Multiple GEHC
Forward P/E Ratio Valuation N/M 14.7x Lower Multiple GEHC
Revenue Growth (YoY) Growth +0.0% +7.2% Higher Growth GEHC
Operating Margin (TTM) Profitability 0.0% 13.8% Higher Margin GEHC
Net Profit Margin Profitability 0.0% 10.0% Higher Margin GEHC
Return on Equity (ROE) Capital Efficiency -226.2% 20.0% Higher ROE GEHC
52-Week Range Position Momentum 41% ($1โ€“$3) 71% ($59โ€“$90) Stronger Trend GEHC
Beta / 30D Volatility Risk Regime 0.94ฮฒ ยท 179% Vol 0.52ฮฒ ยท 39% Vol Lower Realized Risk GEHC
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 38.6 / 100 (SELL) Higher Composite CHEK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CHEK vs GEHC Buy Guide
CHEK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CHEK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GEHC SURGE
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live GEHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CHEK nor GEHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.